These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


264 related items for PubMed ID: 10036957

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C, Triantafyllou K, Mallas E, Triantafyllou G, Ladas SD.
    J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
    [Abstract] [Full Text] [Related]

  • 8. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M, Kato M, Sugiyama T, Satoh K, Kuwayama H, Fukuda Y, Fujioka T, Takemoto T, Kimura K, Shimoyama T, Shimizu K, Kobayashi S, Japan Helicobacter pylori Eradication Study Group.
    J Gastroenterol; 2003 Jul; 38(4):339-47. PubMed ID: 12743773
    [Abstract] [Full Text] [Related]

  • 9. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview].
    Leodolter A, Peitz U, Malfertheiner P.
    Wien Med Wochenschr; 2001 Jul; 151(13-14):300-8. PubMed ID: 11582994
    [Abstract] [Full Text] [Related]

  • 10. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T, Kanoh Y, Higuchi K, Arakawa T, Morisita T.
    Hepatogastroenterology; 2003 Jul; 50(51):607-9. PubMed ID: 12828043
    [Abstract] [Full Text] [Related]

  • 11. [Is the successful eradication of Helicobacter pylori sufficient for the healing of peptic ulcer?].
    Pregun I, Herszényi L, Juhász M, Miheller P, Tulassay Z.
    Orv Hetil; 2006 Mar 12; 147(10):435-9. PubMed ID: 16573172
    [Abstract] [Full Text] [Related]

  • 12. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
    Holtmann G, Layer P, Goebell H.
    Z Gastroenterol; 1996 May 12; 34(5):267-72. PubMed ID: 8686357
    [Abstract] [Full Text] [Related]

  • 13. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ, Lee DH, Kim N, Jung SH, Kim JW, Hwang JH, Park YS, Lee KH, Jung HC, Song IS.
    Hepatogastroenterology; 2007 Jun 12; 54(76):1293-6. PubMed ID: 17629092
    [Abstract] [Full Text] [Related]

  • 14. Peptic ulcer recurrence after Helicobacter pylori eradication: a 5-year follow-up study.
    Fujioka T, Uribe RU, Kubota T, Murakami K, Kawasaki H, Nasu M.
    Eur J Gastroenterol Hepatol; 1995 Aug 12; 7 Suppl 1():S35-8. PubMed ID: 8574733
    [Abstract] [Full Text] [Related]

  • 15. Eradication of Helicobacter pylori followed by reinfection.
    Tonokatsu Y, Fukuda Y, Tsujiai T, Tamura K, Shimoyama T.
    J Gastroenterol; 1996 Nov 12; 31 Suppl 9():75-6. PubMed ID: 8959526
    [Abstract] [Full Text] [Related]

  • 16. Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial.
    Murakami K, Sato R, Okimoto T, Watanabe K, Nasu M, Kodama M, Fujioka T.
    J Gastroenterol Hepatol; 2006 Jun 12; 21(6):1048-53. PubMed ID: 16724993
    [Abstract] [Full Text] [Related]

  • 17. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
    Ando T, Minami M, Mizuno T, Watanabe O, Ishiguro K, Ina K, Kusugami K, Nobata K, Nishiwaki T, Tsuzuki T, Shimada M, El-Omar E, Goto H.
    Helicobacter; 2005 Oct 12; 10(5):379-84. PubMed ID: 16181347
    [Abstract] [Full Text] [Related]

  • 18. Prevention of the rehaemorrhage of bleeding peptic ulcers: effects of Helicobacter pylori eradication and acid suppression.
    Kikkawa A, Iwakiri R, Ootani H, Ootani A, Fujise T, Sakata Y, Amemori S, Tsunada S, Sakata H, Koyama T, Fujimoto K.
    Aliment Pharmacol Ther; 2005 Jun 12; 21 Suppl 2():79-84. PubMed ID: 15943852
    [Abstract] [Full Text] [Related]

  • 19. Peptic ulcer disease: defining the treatment strategies in the era of Helicobacter pylori.
    Hunt RH.
    Am J Gastroenterol; 1997 Apr 12; 92(4 Suppl):36S-40S; discussion 40S-43S. PubMed ID: 9127625
    [Abstract] [Full Text] [Related]

  • 20. Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome.
    Wheeldon TU, Hoang TT, Phung DC, Björkman A, Granström M, Sörberg M.
    Aliment Pharmacol Ther; 2005 Apr 15; 21(8):1047-53. PubMed ID: 15813841
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.